- Trials with a EudraCT protocol (28)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
28 result(s) found for: Retrospective Cohort Study.
Displaying page 1 of 2.
EudraCT Number: 2012-005653-22 | Sponsor Protocol Number: NL13PAR | Start Date*: 2014-08-25 |
Sponsor Name:Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital [...] | ||
Full Title: TachoSil patch application as replacement of closed suction wound drainage by parotid gland surgery; a prospective study. | ||
Medical condition: The surgical procedure of parotidectomy whereby a protid tumor is removed. During this procedure the wound surface will be covered by the surgical sealing patch TachoSil instead of the use of a c... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005262-35 | Sponsor Protocol Number: 16401 | Start Date*: 2013-07-08 | ||||||||||||||||
Sponsor Name:Bayer HealthCare AG | ||||||||||||||||||
Full Title: BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi... | ||||||||||||||||||
Medical condition: Clinically isolated syndrome (CIS) and multiple sclerosis (MS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) SE (Completed) PT (Completed) HU (Completed) CZ (Completed) NO (Completed) AT (Completed) FI (Completed) DK (Completed) GB (Completed) ES (Completed) IT (Completed) SI (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-000640-64 | Sponsor Protocol Number: MOU-2020-01 | Start Date*: 2020-05-26 |
Sponsor Name:Masarykův onkologický ústav | ||
Full Title: 11C-METHIONIN IN DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH AGGRESSIVE GLIOBLASTOM SHOWING A TIME POST-OPERATING PROGRESS BEFORE INITIATING ADJUVANT ONCOLOGICAL TREATMENT | ||
Medical condition: REP (rapid early progression) after glioblastoma operation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000941-11 | Sponsor Protocol Number: GMRA-102,Am.No.1 | Start Date*: 2013-03-27 |
Sponsor Name:Bracco Imaging S.p.A. | ||
Full Title: A PROSPECTIVE MULTICENTER COHORT STUDY EVALUATING THE LONG TERM RETENTION OF GADOLINIUM IN HUMAN BONE AND SKIN AFTER THE RETROSPECTIVE ADMINISTRATION OF MULTIHANCE® OR PROHANCE® IN COMPARISON WITH... | ||
Medical condition: Nephrogenic Systemic Fibrosis (NSF) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001455-32 | Sponsor Protocol Number: WIN001 | Start Date*: 2017-12-15 |
Sponsor Name:Worldwide Innovative Network Association | ||
Full Title: A proof of concept study to explore safety and efficacy of tri-therapy approach in advanced/metastatic NSCLC and retrospectively assess the ability of integrated genomics and transcriptomics to mat... | ||
Medical condition: Patients with advanced/metastatic non-small cell lung cancer (NSCLC) with no documented targetable alterations (EGFR mutation, ALK translocation, ROS1 mutation if available or MET exon 14 skipping ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-001868-36 | Sponsor Protocol Number: SPI-POZ-202 | Start Date*: 2018-10-18 | |||||||||||
Sponsor Name:Spectrum Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer, Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (POZITIVE20-1) | |||||||||||||
Medical condition: Non-Small Cell Lung Cancer, Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) NL (Completed) ES (Prematurely Ended) BE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021624-99 | Sponsor Protocol Number: HIV-TDM-GTKids | Start Date*: 2012-06-14 |
Sponsor Name:Decan of Medical Faculty of Goethe University Frankfurt | ||
Full Title: A multi-centre, non-controlled, non-randomised IST to evaluate the plasma level of antiretroviral substances, the viral resistance profile and their impact on the clinical response in HIV infected... | ||
Medical condition: Paediatric patients with diagnosed HIV1-infection aged 2 to 17 years | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011152-22 | Sponsor Protocol Number: GTG003.08 | Start Date*: Information not available in EudraCT |
Sponsor Name:GENETHON | ||
Full Title: Phase 1/2 clinical trial of haematopoietic stem cell gene therapy for the Wiskott-Aldrich Syndrome | ||
Medical condition: Phase 1/2 clinical trial of haematopoietic stem cell gene therapy for the Wiskott-Aldrich Syndrome. An open labelled, non-randomised, phase I/II, cohort study involving a single infusion of autolo... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003587-39 | Sponsor Protocol Number: COMBAT-MS | Start Date*: 2017-05-22 |
Sponsor Name:Karolinska Institutet | ||
Full Title: COMBAT-MS (COMparison Between All immunoTherapies for Multiple Sclerosis) A prospective long-term cohort study of safety, efficacy and patient’s satisfaction of MS disease modulatory treatments in... | ||
Medical condition: Relapsing-remitting multiple sclerosis (RRMS) that has started on their first or second immunomodulatory drug at the earliest 2011-01-01 and at the latest 2018-06-30. The clinical course and respon... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003124-41 | Sponsor Protocol Number: 219510 | Start Date*: 2023-03-27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:GlaxoSmithKline Biologicals SA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A Phase 3b, non-randomized, open label, multi-country, cohort study to describe the safety of study participants who received RSVPreF3 maternal vaccination (any dose) or controls from previous RSV ... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Pregnancy related outcomes and events in maternal participants who were vaccinated against RSV or received control, and in their infants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FI (Ongoing) BE (Ongoing) DE (Ongoing) FR (Ongoing) ES (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003452-21 | Sponsor Protocol Number: BRF117277 | Start Date*: 2014-01-27 | |||||||||||
Sponsor Name:GlaxoSmithKline, S.A. | |||||||||||||
Full Title: BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain. | |||||||||||||
Medical condition: Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002221-29 | Sponsor Protocol Number: VIT-2763-THAL-201 | Start Date*: 2020-02-25 | |||||||||||
Sponsor Name:Vifor (International) Inc. | |||||||||||||
Full Title: A Phase 2a, Double-blind, Randomised, Placebo-controlled, Parallel Group, Multicentre Study on Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Multiple Doses of... | |||||||||||||
Medical condition: Non-transfusion Dependent Beta-thalassaemia. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001051-32 | Sponsor Protocol Number: 2102-HEM-101 | Start Date*: 2019-03-14 | |||||||||||||||||||||
Sponsor Name:Forma Therapeutics, Inc. | |||||||||||||||||||||||
Full Title: A Phase 1/2, Multicenter, Open-label Study of FT 2102 as a Single Agent and in Combination with Azacitidine or Cytarabine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome with an... | |||||||||||||||||||||||
Medical condition: Relapsed/refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002350-78 | Sponsor Protocol Number: ProBio | Start Date*: 2018-10-22 | ||||||||||||||||
Sponsor Name:Karolinska Institutet | ||||||||||||||||||
Full Title: ProBio: An outcome adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer | ||||||||||||||||||
Medical condition: Patients with metastatic hormone-sensitive and castration-resistant prostate cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: SE (Ongoing) BE (Ongoing) NO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003653-29 | Sponsor Protocol Number: BT5528-100 | Start Date*: 2020-10-09 | |||||||||||
Sponsor Name:Bicycle Tx Limited | |||||||||||||
Full Title: Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT5528 in Patients with Advanced Malignancies Associated with EphA2 Expression | |||||||||||||
Medical condition: Advanced Malignancies Associated with EphA2 Expression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001500-18 | Sponsor Protocol Number: 1403-0011 | Start Date*: 2022-11-07 | ||||||||||||||||
Sponsor Name:Boehringer Ingelheim España S.A. | ||||||||||||||||||
Full Title: Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract ade... | ||||||||||||||||||
Medical condition: cancer in the biliary tract or pancreas | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) NO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004425-27 | Sponsor Protocol Number: 5863 | Start Date*: 2012-05-29 |
Sponsor Name:Newcastle Upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED) SORTED 1 – a Randomised Controlled Trial (Pilot study) SORTED 2 – Qualitative Interviews SORTED 3 – Retrospective Cohort | ||
Medical condition: hypothyroidism (elderly individuals) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001842-82 | Sponsor Protocol Number: W00101-IV-1-01 | Start Date*: 2017-11-15 | |||||||||||
Sponsor Name:PIERRE FABRE MEDICAMENT | |||||||||||||
Full Title: Phase I/II open label dose escalation and dose expansion study of intravenous infusion of W0101, an antibody-drug conjugate, in patients with advanced or metastatic solid tumors. International, mu... | |||||||||||||
Medical condition: Advanced or metastatic solid tumors (excluding lymphoma) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003126-25 | Sponsor Protocol Number: DZ2019E0001 | Start Date*: 2022-02-14 | |||||||||||
Sponsor Name:Dizal (Jiangsu) Pharmaceutical Co., Ltd | |||||||||||||
Full Title: A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with... | |||||||||||||
Medical condition: Non-Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003453-16 | Sponsor Protocol Number: SHP677-304 | Start Date*: 2019-07-31 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: A PHASE 3B, PROSPECTIVE, OPEN-LABEL, UNCONTROLLED, MULTICENTER STUDY ON LONGTERM SAFETY AND EFFICACY OF rVWF IN PEDIATRIC AND ADULT SUBJECTS WITH SEVERE VON WILLEBRAND DISEASE (VWD) | |||||||||||||
Medical condition: severe von Willebrand Disease | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) NL (Ongoing) DE (Ongoing) ES (Ongoing) AT (Ongoing) IT (Ongoing) BE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.